Spot Biosystems
1 known investors
Spot Biosystems develops non-viral gene therapies using an extracellular vesicle (EV) gene delivery platform aimed at improving the safety and efficacy of treatments for diseases, initially targeting Duchenne muscular dystrophy.
Investors · 1
Frequently asked questions
- What does Spot Biosystems do?
- Spot Biosystems develops non-viral gene therapies using an extracellular vesicle (EV) gene delivery platform aimed at improving the safety and efficacy of treatments for diseases, initially targeting Duchenne muscular dystrophy.
- Who are Spot Biosystems's investors?
- Spot Biosystems's investors include Saltagen Ventures.